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ABSTRACT
Salinomycin is an ionophore with antimicrobial properties. It is a dietary additive used as a growth promoter 
for ruminants and as a coccidiostat in chickens. However, over-dosage or misuse situations can lead to a series of 
toxic syndromes. Cardiac troponin I (cTnI) is the part of the troponin complex (I, C and T) within the sarcomere 
in myocardial cells that regulates contraction of the heart muscle. cTnI is released from injured myocardiocytes 
into circulation, so it can be a specifi c biomarker in myocardial necrosis. The purpose of this study is to propose 
cTnI for diagnostic cardiac degeneration induced by experimental toxicosis with salinomycin in sheep. Twenty 
Iranian mixed breed adult female fat-tailed sheep (BW: 33.3 ± 3.4 kg) were used in this study. The sheep were 
randomly divided in to fi ve equal groups. Group I (control) received 20 mL normal Saline. Groups II, III, IV 
and V were orally administered 1 mg/kg (twice a day for two days), 2, 3 and 4 mg/kg (once a day for two 
days) salinomycin, respectively. Following drug administration, blood samples were collected at different time 
intervals (2, 5, 8, 14 and 21 days) in order to determine various biochemical parameters (cTnI, CK, LDH, ALT 
and AST). In all groups, the heart sounds of the animals were carefully heard and electrocardiogram (ECG) 
was taken to determine the type of probable arrhythmia. The results illustrated a signifi cant increase in the 
activity of cTnI. Numerous arrhythmias were recorded, such as: sinus tachycardia, supraventricular tachycardia, 
sinus arrhythmia and supraventricular premature contraction. All animals with arrhythmias showed a signifi cant 
increase in the activity of cTnI. Cardiac muscle necrosis observed macroscopically on post mortem examination 
revealed myocardial degeneration. Overall, the results of this study indicate that cTnI may be considered as a 
valuable biomarker in diagnosing cardiac degeneration due to salinomycin toxicosis.
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Introduction 
Salinomycin is a monocarboxylic polyether antibiotic produced by Streptomyces 
albus. It is used to prevent coccidiosis in chickens and is also added to feed to improve 
feed effi ciency in beef cattle (BASTIANELLO et al., 1996; RIZVI, 1999). Due to the fact that 
the ionophorous anticoccidials currently used have a narrow margin of safety and some 
of them are highly toxic to several animal species, the considerable concern for their safe 
application is entirely justifi ed (VACZI et al., 2006). Toxic doses of these drugs vary and 
depend on the ionophore compound and the species of animals (GALITZER et al., 1986). 
Moreover, because of its favorable hemodynamic profi le, salinomycin has the potential 
as a drug to increase cardiac output, blood pressure and left ventricular contraction 
force, and for improving the myocardial blood perfusion and mechanical effi ciency of 
the heart (OZAKI et al., 1982). Salinomycin has been shown to exert an inotropic effect 
(GUPTA et al., 2005; SATOH and TSUCHIDA, 1999). This effect has been mostly attributed 
to the release of endogenous catecholamines (GAIDE et al., 1984), although Rajaian et al 
have proposed that the inhibition of catecholamine metabolism may also be involved 
(RAJAIAN et al., 2009). In clinical medicine, numerous serum biomarkers are used, or 
proposed for use, in the diagnosis of myocardial injury, including acute myocardial 
infarction (AMI). All of these biomarkers are macromolecules found in cardiac myocytes 
and their appearance in the serum is indicative of myocyte injury. Only CK-MB, cTnI, 
cTnT, myoglobin, and LDH have achieved wide clinical acceptance, not only for AMI, 
but for other forms of myocardial injuries (APPLE, 1999). Cardiac troponin is the ‘gold-
standard’ biomarker of myocardial injury in humans because of its high tissue specifi city, 
diagnostic sensitivity, low basal blood concentration, rapid release, and persistence in the 
blood. Studies in humans (ADAMS et al., 1993) and rats (YORK et al., 2007) indicated good 
correlation between the severity of morphologically detectable myocardial cell damage 
and blood troponin I concentrations. Serum concentrations of cTn correlate well with the 
histopathological changes in the myocardium, cardiac pathophysiology, extent of cardiac 
injury, clinical signs and prognosis. Use of cTn in veterinary medicine and in pre-clinical 
toxicology is growing rapidly (O’BRIEN et al., 1997; WELLS and SLEEPER, 2008). cTnI 
can be a marker in trauma, including traumatic reticuloperitonitis in cattle (GUNES et al., 
2008). GUNES et al. (2005) suggest that cardiac troponin tests designed for use in human 
beings could also be used in the diagnosis of myocardial degeneration due to foot-and-
mouth disease in calves. Studies in lambs with white muscle disease demonstrated that 
cTn kits used for humans can effectively determine myocardial degeneration in these 
animals (GUNES et al., 2010). 
In the present study, ECG parameters and the types of arrhythmias were examined in 
sheep intoxicated experimentally with salinomycin. In addition, changes in biochemical 
parameters were also studied in the intoxicated animals.
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Materials and methods
Twenty Iranian mixed breed adult female fat-tailed sheep weighing 33.3 ± 3.4 kg 
were stable-fed ad libitum with a mixture of alfalfa hay, corn silage and barley. The sheep 
were randomly divided into fi ve equal experimental groups. Sodium salinomycin was 
orally administered. Group one (control) received 20 mL normal saline. Groups II, III, IV 
and V were given 1 mg/kg (twice a day for two days), 2, 3 and 4 mg/kg (once a day for 
two days) salinomycin, respectively. Following drug administration, blood samples were 
collected from the jugular vein into vaccutainers at different intervals (2, 5, 8, 14 and 21 
days), in order to determine various biochemical parameters (cTnI, CK, LDH, ALT and 
AST). The sera were separated by centrifugation at 750×g and were kept at -20 °C until 
analysis. To ensure the expected concentrations of our parameters, the frozen samples 
were sent to the laboratory for analysis within 48 hours. After arrival at the laboratory, 
the samples were thawed at room temperature and analyzed immediately. Biochemical 
analysis was carried out to measure serum ALT and AST activities by the colorimetric 
method of Reitman and Frankel (REITMAN and FRANKEL, 1957), CK by the Sigma 
colorimetric (modifi ed Hughes) method, and LDH by the Sigma colorimetric method. 
The biochemical parameters were measured using appropriate commercial laboratory kits 
with RA1000 spectrophotometer.
A commercially available ELISA kit, cTnI AccubindTM Elisa assay (Monobind 
Inc) was used to determine the concentration of cTnI according to the manufacturer’s 
instructions. The optical densities of the samples were compared with a standard curve 
prepared for standards containing 0 to 3 ng/mL of cTnI derived from human hearts. All 
the enzyme activities were measured at 37 °C and the results are presented in U/L. 
ECG recording. Heart sounds of the sheep in both groups were carefully 
monitored before and after the administration of either salinomycin or Saline solution. 
Electrocardiograms (ECGs) were recorded to evaluate the presence and types of 
arrhythmias. A base-apex lead was used to record the ECG by Kenz ECG recorder model 
110 (Suzuken Co., Japan). This lead was attached by placing the positive electrode on the 
left thorax, located in the fi fth intercostal space, at the level of the point of the elbow or 
where the apex beat was most readily palpated. The negative electrode was attached to the 
skin on the right jugular furrow, two-thirds of the way from the ramus of the mandible to 
the thoracic inlet. The ground electrode was attached to a location remote from the heart. 
A base-apex lead ECG was recorded from each animal, at a paper speed of 25 mm/s and 
calibration of 10 mm/mV (1 cm = 1 mV). The ECGs of control sheep were used to obtain 
normal values for heart rate, amplitude, duration, confi guration, segments (PR and ST) 
and intervals (PP, RR, PR and QT).
This study was approved by the research committee of Shiraz University according 
to the animal welfare regulations.
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Statistical analysis. All data are presented as mean ± SEM and were analyzed by proc 
mixed procedure using SAS for Windows release 9.11 computer software (SAS Institute 
Inc., Cary, NC). Time and dose groups, as well as their interaction, were considered as the 
main effects in the statistical model. The Tukey test was used to determine the signifi cant 
differences between group means. In all analyses, a P value less than 0.05 was considered 
signifi cant.
Results
Clinical signs. Clinical signs noticed after oral administration of salinomycin were: 
inappetence, non-coordination, dehydration, increased respiration, tachycardia, muscular 
weakness, salivation, continual panting, prostration and paralysis, groan, tremors, increased 
body temperature and heart rate, oral and nasal discharge and bruxism. Advanced clinical 
signs in sheep that later died included severe tachycardia and tachypnea, associated with 
hind limb ataxia. One sheep from group 2 (1 mg/kg), and one sheep from group 5 (4 mg/
kg), died within 72 h after the administration of salinomycin. In the control group there 
were no abnormal clinical signs during the experiment. 
Pathology. The two dead sheep were examined within 12 hours post mortem. 
Postmortem examination revealed congestion and edema of the skeletal muscles, swelling 
and hemorrhagic foci in peripheral lymph nodes, hydrothorax and hydropericardium, 
petechial hemorrhage in fat tissues of the heart base on the epicardium, severe pulmonary 
congestion and edema, and also the presence of moderate frothy fl uid in the trachea 
and bronchi. In the heart muscle, myocardial degeneration and necrosis, without any 
infl ammatory reaction or calcifi cation, and epicardial hemorrhage within deposited fat 
cells were diagnosed.
Biochemical parameters. The various degrees of changes in several biochemical 
parameters in all these groups are demonstrated in Table 1.
AST. On day 2, there was a signifi cant (P<0.01) increase in the activity of AST in 
group V compared to all the other groups, except group II. The increase in AST activity 
on day 2 in group V was also signifi cantly (P<0.01) different from those in succeeding 
time intervals. 
ALT. There were signifi cant differences in the activity of ALT with different doses of 
salinomycin (P<0.01). The serum ALT level in group V was signifi cantly higher than all 
other groups, except group II. However, there were no signifi cant (P = 0.39) differences 
with respect to different times (P = 0.20). 
LDH. There were no signifi cant (P = 0.07) differences in the activity of LDH with 
various doses of salinomycin and also with respect to different times (P = 0.09) in all 
groups.
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Table 1. Serum biochemical parameters (mean ± SEM; n = 4) after oral administration of different 
doses of salinomycin in sheep.
Groups Days AST (IU/L) ALT (IU/L) LDH (IU/L) CK (IU/L) cTnI (ng/mL)
Control
2 118 ± 21 b 15 ± 3 764 ± 49 375 ± 93 b 0.30 ± 0.02
5 86 ± 9 14 ± 1 404 ± 91 236 ± 31 0.39 ± 0.06 b
8 107 ± 14 15 ± 1 912 ± 101 284 ± 36 0.39 ± 0.02
14 218 ± 22 30 ± 9 986 ± 30 275 ± 19 0.39 ± 0.02
21 130 ± 21 28 ± 5 671 ± 59 298 ± 58 0.39 ± 0.20
1 mg/kg
2 1232 ± 690 ab 123 ± 75 3690 ± 2118 5492 ± 3280 aA 0.51 ± 0.05B
5 2818 ± 1909 344 ± 231 3506 ± 1925 1169 ± 657 B 1.93 ± 0.81A
8 301 ± 143 143 ± 92 1863 ± 801 261 ± 60 B 0.76 ± 0.05B
14 425 ± 224 250 ± 88 1907 ± 740 328  ± 64 B 0.52 ± 0.06B
21 138 ± 15 38 ± 8 890 ± 109 242 ± 6 B 0.61 ± 0.06B
2 mg/kg
2 86 ± 6 b 16 ± 4 1313 ± 329 320 ± 28 b 0.64 ± 0.08
5 106 ± 6 33 ± 2 1017 ± 152 293 ± 40 0.86 ± 0.03b
8 110 ± 7 18  ± 3 1053 ± 54 229 ± 32 0.71 ± 0.06
14 130 ± 4 49 ± 12 936 ± 37 568 ± 78 0.73 ± 0.10
21 123 ± 8 16 ± 2 880 ± 67 366 ± 13 0.60 ± 0.08
3 mg/kg
2 73 ± 10 b 11 ± 0 980 ± 84 306 ± 20 b 0.71 ± 0.02
5 107 ± 9 19 ± 0 808 ± 29 241 ± 15 0.72 ± 0.04b
8 118 ± 14 16 ± 1 682 ± 154 270 ± 16 0.78 ± 0.05
14 135 ± 12 35 ± 15 912 ± 249 372 ± 34 0.68 ± 0.05
21 146 ± 22 13 ± 2 813 ± 50 263 ± 34 0.63 ± 0.05
4 mg/kg
2 4665 ± 2566 aA 521 ± 283 10656  ± 7580 1560 ± 1081 b 0.78 ± 0.05
5 685 ± 583 B 749 ± 554 1716  ± 857 566 ± 308 0.69 ± 0.05b
8 320 ± 207 B 316 ± 226 1402 ± 478 307 ± 56 0.91 ± 0.13
14 150 ± 30 B 20a 1047 ± 99 430 ± 26 0.79 ± 0.04
21 150 ± 32 B 27 ± 7 1220 ± 311 422 ± 56 0.67 ± 0.06
For each parameter, small superscripts show signifi cant difference between various groups in each day of 
experiment, and large superscripts show signifi cant difference between various days of experiment in each 
group (P<0.05).
CK. The signifi cant (P = 0.03) interaction between various groups and times for CK is 
demonstrated in Table 1. There were signifi cant differences in the activity of CK in group 
II compared with other groups at day 2 of the experiment (P<0.05). CK increase at day 2 
in group II was also signifi cantly different when compared with succeeding time intervals 
in the same group (P<0.01). 
cTnI. The signifi cant (P = 0.004) interaction between various groups and times for 
cTnI is demonstrated in Table 1. On day 5, there was a signifi cant (P<0.01) increase in the 
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cTnI in group II compared with other groups. cTnI serum levels also showed a signifi cant 
(P<0.001) increase on day 5 compared with the succeeding time intervals in group II. 
ECG records (arrhythmias). ECG records indicate that the heart rate in the control 
group (122 ± 18 beats/min) was signifi cantly (P<0.05) lower than in the experimental 
sheep (210 ± 36 beats/min). In the control animals, a normal heart rhythm was noticed in 
all cases except for sinus tachycardia (3 cases) and sinus arrhythmia (2 cases). Numerous 
arrhythmias were recorded in the experimental sheep, such as: sinus tachycardia (15cases), 
supraventricular tachycardia (7 cases), sinus arrhythmia (3 cases) and supraventricular 
premature contraction (2 cases). Signifi cant increase in cTnI activity was demonstrable in 
all animals showing various types of cardiac arrhythmias. 
Discussion
Degenerative myopathy and myocardiopathy are the main injuries reported in the 
intoxicated animals with salinomycin (KHODAKARAM TAFTI et al., 2008). Ionophores 
form complexes with cations and mediate their transport across the cell membrane in 
response to diffusion gradient, and so mitochondrial failure and depletion of cellular 
adenosine triphosphate (ATP) may occur as ATP-dependent pumps attempt to compensate 
for the infl ux of ions. In addition, failure of calcium ion retrieval from the cytosol and 
ultimate myofi bril hypercontraction, degeneration and necrosis may occur. Therefore, 
highly energetic tissues in the body, such as myocardium and skeletal muscles, are 
primarily affected. It should be mentioned that changes in transmembrane ion gradients and 
electrical potential often produce profound effects on cellular functions and metabolism 
(BLANCHARD et al., 1993). Toxicity is seen when ionophores are administered at the wrong 
dose and to the wrong species (McKELLAR and LAWRENCE, 1996). This is refl ected in 
the emergence of numerous arrhythmias in the sheep intoxicated with salinomycin in the 
present study. This fi nding is consistent with the observations by AGAOGLU et al. (2002).
Blood tests for the diagnosis of cardiac injury in animals are inadequate. Although 
troponin complex proteins have been determined in animals, there is a limited number 
of studies concerning their clinical or paraclinical use. Studies in animals have mainly 
included laboratory animals and have been designed on the basis of myocardial injury 
detection in human beings (CHARLES et al., 2000; FREDERICKS et al., 2001). Clinical trials 
have indicated that serum cardiac troponins are the fi rst biochemical markers to appear 
during the course of acute coronary disease in human beings (BOCCARA et al., 2000). 
Detection of cTnI and cTnT is correlated with loss of cardiac function in toxicity studies 
in rodents and rabbit (SERRA et al., 2010). Use of cTnI as a diagnostic tool in cattle has been 
mentioned in a few studies. Early and accurate identifi cation of myocardial injury may 
be important for the diagnosis, risk stratifi cation, and treatment of cattle with primary or 
secondary myocardial diseases (VARGA et al., 2009). Utilization of tests for the evaluation 
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of cardiac troponins may enable veterinarians to diagnose myocardial degeneration due to 
FMD in cattle herds (GUNES et al., 2005). Myocarditis in domestic animals may result in 
sudden death. The diagnosis of myocarditis in farm animals is important, because in such 
cases the animals may be slaughtered before sudden death. Therefore, cardiac markers, 
such as troponins, could be used to diagnose myocarditis in animals (GUNES et al., 2005). 
All cTnI concentrations in clinically healthy dairy cows are found to be ≤0.03 ng/mL, 
resembling those concentrations reported by others in cattle (JESTY et al., 2005; MELLANBY 
et al., 2007; PEEK et al., 2008). The half-life of troponin and its complex in the circulation 
is about 2 hours (KATUS et al., 1989). In humans with acute myocardial infarction (AMI), 
the cTn level begins to rise 4-12 hours after the infarction, and it reaches its peak value 
12 to 48 hours later (BABUIN and JAFFE, 2005). The initiation of necrotic process in the 
myocardium due to salinomycin intoxication was not revealed in this study. Levels of 
cTnI in the blood increased dependent on salinomycin intoxication, and maximum levels 
were achieved 48 to 72 hours following the administration of the ionophore in all groups. 
In human cardiomyocytes, approximately 6-8% of the total cellular cardiac troponin is 
cytosolically dissolved and thus unbound in the cytoplasm (ADAMS et al., 1994). Soon after 
myocardial cell injury, by affecting cell membrane permeability, some of this free pool is 
liberated into the blood stream. However, the majority of cTnI is retained intracellularly 
because of its structural linkage to the contractile apparatus. Thus, the release of cTnI may 
occur either monophasically, with only a minor increase after reversible myocyte injury, 
or polyphasically with more severe injury of the myocardium, affecting the structurally 
bound portion of cTnI (VARGA et al., 2009). A persistent increase in cTnI concentrations 
in the blood suggests irreversible and active cardiomyocyte damage (O’BRIEN et al., 2006; 
STANTON et al., 2005; WELLS and SLEEPER, 2008). In this study, cTnI concentrations in 
all intoxicated groups were higher than in the control group. Myocardial damage caused 
by salinomycin poisoning is irreversible. The peak release of cTnI into the blood was 
achieved on the fi fth day after intoxication in group II (1.93 ± 0.81 ng/mL) and on day 8 
in group V (0.91 ± 0.13 ng/mL). In addition, the major cardiac injury was seen in these 
two groups. Cardiac muscle necrosis found in post mortem examination in two cases of 
these groups revealed myocardial degeneration and, therefore, justifi es our conclusion. 
 Remarkable differences in the serum activity of CK were found on day 2 between 
group II (1 mg/kg twice a day for two days), with other groups receiving salinomycin. 
CK increase on day 2 in group II was signifi cant, when compared with the following days 
in the same group. Increased serum activity of CK is probably due to a characteristic 
myopathy and probable necrosis, or reversible myocyte damage (STOCKHAM and SCOTT, 
2002). The higher sensitivity of cTnI for the detection of myocardial injury was noticed 
compared with that for CK as described by other investigators (OOI et al., 2000). Serum 
cTnI and CK appeared to increase soon after salinomycin intoxication (day 2) and an 
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association between cTnI concentration, cardiac arrhythmias, and myocardial necrosis 
was found in this study, which is in accordance with other studies (AGAOGLU et al., 
2002; KHODAKARAM TAFTI et al., 2008). There were remarkable differences between the 
activity of ALT with various doses of salinomycin, and in the dose group V (4 mg/kg) it 
was signifi cantly higher than all other groups, except group II (1 mg/kg twice a day for 
two days). The highest levels of cTnI, CK, AST and LDH in the serum were observed on 
the second day of sampling in group II (1 mg/kg twice a day for two days). 
Creatine kinase and or LDH may exhibit several of the characteristics of an 
ideal biomarker with respect to the identifi cation of myocardial injury. In addition, 
methodologies for their measurement are reasonably standardized and readily available. 
However, these lack specifi city for cardiac damage, and these enzymes may be elevated 
in various disease states associated with skeletal muscle, kidney, and/or central nervous 
system injury (CHRISTENSON and AZZAZY, 1998; FREDERICKS et al., 2001). The kinetics 
of these proteins following myocardial injury also limits their use as cardiac biomarkers. 
Furthermore, measurement of the serum levels of these proteins cannot be substantially 
correlated with the extent of myocardial injury or disease progression (BERTINCHANT 
et al., 2000). It is clear that CK, ALT, AST, and LDH have limitations as biomarkers of 
myocardial injury and, therefore, more specifi c and more sensitive cardiac biomarkers 
could improve safety assessment and monitoring in preclinical and clinical research 
(WALLACE et al., 2004). 
In conclusion, the results of this study may indicate that cTnI is a valuable biomarker 
in the diagnosis of cardiac degeneration due to salinomycin toxicosis in sheep.
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SAŽETAK
Salinomicin je ionofor s antimikrobnim svojstvima. Rabi se kao dodatak hrani koji u preživača ima ulogu 
promotora rasta, a u pilića ulogu kokcidiostatika. Prevelike količine i pogrešna uporaba salinomicina mogu 
dovesti do teških sindroma trovanja. Srčani troponin I (cTnI) je dio troponinskog kompleksa  (I, C i T), unutar 
sarkomere srčanih mišićnih stanica, koji regulira kontrakcije srčanog mišića. Budući da se  oslobađa iz oštećenih 
miokardiocita u krvotok,  cTnI može biti specifi čan biomarker kod nekroze srčanog mišića. Svrha istraživanja 
bila je predložiti da se cTnI primjeni u dijagnostici srčane degeneracije uzrokovane pokusnim trovanjem ovaca 
salinomicinom. U istraživanje je bilo uključeno 20 odraslih, masnorepih ovaca, križanki iranskih pasmina 
(TM: 33,3 ± 3,4 kg). Ovce su metodom slučajnog izbora bile podijeljene u pet skupina iste veličine. Skupina 
I (kontrola) dobila je 20 mL otopine soli. Skupine II, III, IV i V dobile su oralnim putem salinomicin i to u 
količini od 1 mg/kg (dva puta dnevno kroz dva dana), odnosno 2, 3 i 4 mg/kg (jednom dnevno kroz dva dana). 
Odmah nakon toga uzimani su uzorci krvi u različitim vremenskim razmacima  (2, 5, 8, 14 i 21 dana) s ciljem 
određivanja različitih biokemijskih pokazatelja (cTnI, CK, LDH, ALT i AST). U svim skupinama pažljivo 
su osluškivani srčani tonovi i određivan elektrokardiogram s ciljem otkrivanja tipa moguće srčane aritmije. 
Rezultati pokazuju značajno povećanje aktivnosti cTnI. Zabilježene su i mnoge aritmije kao što su sinusna 
tahikardija, supraventrikularna tahikardija, sinusna aritmija i supraventrikularna preuranjena kontrakcija. Sve 
su životinje uz aritmiju očitovale i značajno povećanje aktivnosti cTnI. Razudbom nakon uginuća makroskopski 
je opažena nekroza i degeneracija srčanog mišića. Zaključno, rezultati istraživanja pokazuju da cTnI može biti 
vrijedan biomarker u dijagnostici srčane degeneracije prouzročene trovanjem salinomicinom.
Ključne riječi: trovanje salinomicinom, ovca, troponin I, biokemijski pokazatelji, aritmija________________________________________________________________________________________
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